Nationality
Canada, US

Year of Birth
1958

1983
Queen’s University, Kingston, Canada, M.D

1989
California Institute of Technology, Pasadena, Biology, M.Sc.

1994
University of California, San Francisco, Neuroscience, Ph.D.

1994–1998
Stanford University, Biochemistry, Postdoctoral fellow

1984-1987
Harvard Medical School, Resident in Neurology

1987
Harvard Medical School, Chief Resident in Neurology

1989–1998
University of California, San Francisco, Adjunct Clinical Appointment in the Department of Neurology

1997–2006
Cytokinetics, Co-founder, President  and CEO

2008–2010
Arete Therapeutics, President and CEO

2010–2013
Genentech Partnering, Global Head and Vice President

2013–2018
Genentech Partnering, Global Head and Senior Vice President

Since 2018
Roche Basel, Global Head of Pharma Partnering

Since 1998
Member of Scientific Advisory Board at Cytokinetics

2005–2016
Member of the Board of Directors of HopeLab

2007–2008
Executive Chairman of the Board of Directors of Cytokinetics

2008–2010
Chairman of the Board of Directors of Cytokinetics

2015–2016
Member of the Board of Directors of California Life Sciences Association

2016–2020
Member of the Board of Directors of Coalition for the Life Sciences

Since 2019
Member of the Board of Directors, Chugai Pharmaceutical Co., Ltd


This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.